Championing mental health: IOCs blueprint for major sports events
31 October 2024 - Following the positive impact of the mental health services provided…
Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update
November 04, 2024 02:00 ET | Source: Verona Pharma plc Ohtuvayre™ (ensifentrine) launch…
OSE Immunotherapeutics Announces Statistically Significant and Clinically Meaningful Results from the Phase 2 Study of Anti-IL7R mAb Lusvertikimab for the Treatment of Ulcerative Colitis
OSE Immunotherapeutics Announces Statistically Significant and Clinically Meaningful Results from the Phase…
QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics
Germantown, Maryland, and Venlo, the Netherlands, Nov. 04, 2024 (GLOBE NEWSWIRE) --…
Telix Welcomes CMS Decision to Improve Payments for Diagnostic Radiopharmaceuticals
November 03, 2024 17:03 ET | Source: Telix Pharmaceuticals Limited MELBOURNE, Australia,…
Belite Bio Announces Exercise of Warrants for US$28.75 Million Gross Proceeds
November 03, 2024 16:00 ET | Source: Belite Bio, Inc SAN DIEGO,…
Optimal Breathing Holds its Annual Black Friday Sale
FORT MILL, S.C., Nov. 02, 2024 (GLOBE NEWSWIRE) -- Optimal Breathing will…
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 01, 2024 19:04 ET | Source: ZENTALIS PHARMACEUTICALS SAN DIEGO, Nov.…
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 01, 2024 18:32 ET | Source: LENSAR, Inc. ORLANDO, Fla., Nov.…
HeartFlow Announces New Decision from Centers for Medicare & Medicaid Services Boosting CCTA Reimbursement and Access
November 01, 2024 18:14 ET | Source: HeartFlow Holding, Inc. — Hospital…